MarketInOut Stock Screener Log In | Sign Up

Medicure Inc

TSXV • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/30/2026
Medicure Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeTSXV
Market Capitalization45.92 mln
Float7.57 mln
Earnings Date11/20/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-3.45
Reliable

Relative Strength

84 / 100
Strongly outperforming

Debt / Equity

0.06
Debt-free

Pre-Tax Margin

-23%
Deeply loss-making

ROE

-51.20
Deeply negative

Business Description

Medicure Inc. is a Canadian biopharmaceutical company founded in 1997 that develops and sells medicines for serious medical conditions in the United States. Its two main products treat heart-related emergencies and high cholesterol, while two additional treatments for rare neurological disorders are currently in development. Customers can purchase its products through retail stores, mail-order services, and online pharmacies.

Key Fundamentals

EPS-0.71
ROE-51.20
RPS3.07
ROIC-51.50
ROA-29.55
Interest Cover-234
EBITDA, mln-4.58
EV / EBITDA-9.78
EV / EBIT-6.18
Revenue, mln32.08
EV / Revenue1.40

Quote Details

Last 4.30
Change -0.1 (-2.27%)
Open 4.42
Volume 21,100
Turnover 90,730
Average Volume 6,471.57

Financial Ratios

Pre-Tax Profit Margin-23
Leverage Ratio1.95
Current Ratio0.97
Price / Book4.00
Price / Tangible Book222
Debt / Equity0.06
Price / Sales1.44
PEG Ratio0.17

Financial Strength

Altman Z-Score-1.86
Piotroski F-Score 4 / 9
Beneish M-Score-3.45
Price to Intrinsic Value2.30
Short Ratio1.79
Short % of Float0.07

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 2.38% 79 / 100   
1 Month 58.09% 99 / 100   
2 Months 231% 99 / 100   
6 Months 244% 99 / 100   
1 Year 418% 99 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog